Minigenes produced by CRISPR combat liver disease in mice
A new gene-editing technique based on CRISPR was used to successfully avoid the development of a liver disease that can be caused by hundreds of mutations, as well as to ease the symptoms in mice. This proof-of-concept study was published online in the journal Science Advances in February 2020.
No hay comentarios:
Publicar un comentario